Condition

Relapsed Primary Central Nervous System Lymphoma clinical trials and research

• 2Clinical trials
• 7Countries

All recruiting trials (2)

• Epcoritamab plus ibrutinib for central nervous system lymphoma

  This trial tests whether combining epcoritamab and ibrutinib is safe and tolerable for adults with relapsed or refractory primary or secondary central nervous system lymphoma.

  Recruiting at 8 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 7 other locations · NCT07082868

• Evaluating Emavusertib for Relapsed or Refractory Primary Central Nervous System Lymphoma

  This study is testing a new drug called emavusertib, alone and with another medication, to see if it can help adults with tough-to-treat primary central nervous system lymphoma feel better.

  Recruiting at 35 sites Phase 1/2 Curis, Inc. · Phoenix, Arizona and 44 other locations · NCT03328078

Related topics

Quick answers

How many Relapsed Primary Central Nervous System Lymphoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (2 trials), Czechia (1 trial), France (1 trial), Israel (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →